Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that specifically bind to the EphA2 receptor

Antibodies that specifically bind to the EphA2 receptor

US Patent 9676864 · Granted Jun 13, 2017

Estimated economic value: $15,470,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19 antibodies and uses therof2024
Cryptophycin antibody conjugates for the treatment of cancer2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Anti-CD123 antibodies and conjugates and derivatives thereof2024
Conjugates comprising cell-binding agents and cytotoxic agents2023
CD37-binding molecules and immunoconjugates thereof2022
Antibodies that bind IL-4 and/or IL-13 and their uses2022
Anti-CD123 antibodies and conjugates and derivatives thereof2022
Anti-CEACAM5 antibodies and uses thereof2022
Method for identifying an ovarian cancer in a subject likely to respond to anti-2021
Antibodies and assays for detection of CD372021
Cryptophycin antibody conjugates for the treatment of cancer2021